Literature DB >> 21411774

Combined core needle biopsy and fine-needle aspiration with ancillary studies correlate highly with traditional techniques in the diagnosis of nodal-based lymphoma.

Catalina Amador-Ortiz1, Ling Chen, Anjum Hassan, John L Frater, Richard Burack, TuDung T Nguyen, Friederike Kreisel.   

Abstract

Core needle biopsy (CNB) and fine-needle aspiration (FNA) are increasingly replacing excisional lymph node biopsy in the diagnosis of lymphomas. However, evaluation of CNB and FNA remains challenging owing to limited architectural information and the more detailed subclassification of lymphomas required by the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Our study is the largest study to assess diagnostic accuracy of CNB and FNA in conjunction with ancillary studies. We analyzed 263 cases and a diagnosis was established in 237, of which 193 were completely subclassified. In cases in which excisional biopsy was available as a reference for comparison, CNB and FNA had a sensitivity of 96.5%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 90%. CNB and FNA with ancillary studies represent a viable alternative in the diagnosis of lymphoma, as long as the number and size of cores for morphologic studies are not compromised.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411774     DOI: 10.1309/AJCP3WZ8ZDRJQDOU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  [A plea for cytopathology].

Authors:  P Dalquen
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

Review 2.  Endoscopic ultrasound guided fine needle tissue acquisition: where we stand in 2013?

Authors:  Zeid Karadsheh; Mohammad Al-Haddad
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.

Authors:  Masahiro Uni; Fumihiko Nakamura; Akihide Yoshimi; Aya Shinozaki-Ushiku; Atsuko Hosoi; Kumi Nakazaki; Yasuhito Nannya; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 4.  Nodular fasciitis in the axillary tail of the breast.

Authors:  Dejan Samardzic; Alison Chetlen; Jozef Malysz
Journal:  J Radiol Case Rep       Date:  2014-05-31

5.  Laparoscopy has a superior diagnostic yield than percutaneous image-guided biopsy for suspected intra-abdominal lymphoma.

Authors:  Shaun C Daly; Matthew Klairmont; Bulent Arslan; Yalini Vigneswaran; Kevin F Roggin; Michael B Ujiki; Woody Denham; Keith W Millikan; Minh B Luu; Daniel J Deziel; Jonathan A Myers
Journal:  Surg Endosc       Date:  2014-12-10       Impact factor: 4.584

6.  Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.

Authors:  Sudipta Pandit; Sabyasachi Choudhury; Anirban Das; Sibes Kumar Das; Soumya Bhattacharya
Journal:  J Health Popul Nutr       Date:  2014-03       Impact factor: 2.000

7.  Benign granular-cell tumor of the breast: Case report and literature review.

Authors:  Devi Meenal Jagannathan
Journal:  Radiol Case Rep       Date:  2016-02-17

8.  Advantage of urological experience with both transperitoneal and retroperitoneal laparoscopy in lymph node biopsy for malignant lymphoma diagnosis.

Authors:  Hiroaki Kawanishi; Katsuhiro Ito; Satoshi Kamido; Yuka Kohno; Toshihiro Uemura; Keiji Kato; Hirotsugu Uetsuki; Hitoshi Ohno; Kazuhiro Okumura
Journal:  Investig Clin Urol       Date:  2016-10-25

9.  Lymphadenopathy: Differentiation between Tuberculosis and Other Non-Tuberculosis Causes like Follicular Lymphoma.

Authors:  Karan Thakkar; Saket Mukund Ghaisas; Manmohan Singh
Journal:  Front Public Health       Date:  2016-02-25

10.  De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning.

Authors:  Paul D Simonson; Yue Wu; David Wu; Jonathan R Fromm; Aaron Y Lee
Journal:  Am J Clin Pathol       Date:  2021-11-08       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.